Hungarian scientists reveal the effectiveness of the Chinese vaccine
Change language:
A recent Hungarian study shows that the lack of antibodies does indeed suggest lower protection against Covid-19.
As HVG reported, researchers measured the neutralising antibodies of people vaccinated with the Sinopharm vaccine and compared the results with the disease data of people also vaccinated with the Chinese vaccine.
With this, it was revealed that antibody levels are indeed a good predictor of immunity and that the lack of antibodies in elderly people vaccinated with the Chinese vaccine does suggest that they are less protected against Covid-19.
As Telex wrote, the results of the research were published in the scientific journal BMC Infectious Diseases, and they found that while 90% of people under the age of 50 had measurable levels of the antibody, 25% of people over 60 and 50% of people over 80 had no neutralising antibodies.
“Based on these findings, it seems clear that elderly people vaccinated with Sinopharm are much less protected against the coronavirus than younger people.”
The authors of the study are Tamás Ferenci, associate professor and biostatistician at the University of Óbuda, and Balázs Sarkadi, an academic and medical biochemist at the Natural Sciences Research Centre of the Eötvös Loránd Kutatási Hálózat (Eötvös Loránd Research Network, ELKH).
